Newcells Biotech Limited

Newcells Biotech Limited

Newcells Biotech Limited

Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the decision-making process in drug development by providing best in class in vitro models that most accurately predict in vivo outcomes. Strong links with global Pharmaceutical and Biotech companies and academic centres of excellence. Newcells builds functionally relevant in vitro models that accurately predict in vivo outcomes. Globally recognised scientific expertise and innovation is embedded in all it’s products and services. Using our expertise in induced pluripotent stem cells (iPSCs), cellular physiology and organoid technology, we engineer models of kidney, retina, liver and lung from patient samples as well as from a range of preclinical species.

Company details

The Biosphere Drayman’s Way Newcastle Helix , Newcastle Upon Tyne , NE4 5BX United Kingdom
View in map

Find locations served, office locations

Business Type:
Manufacturer
Industry Type:
Pharmaceuticals
Market Focus:
Globally (various continents)

  • Based in Newcastle upon Tyne, UK
  • Founded in 2015 with academics from Newcastle University
  • Strong links with global Pharmaceutical and Biotech companies and academic centres of excellence
  • State of the art facilities located in The Helix science campus
  • Fast growing company – growing to 100 employees by 2025
  • £10M raised since its inception, £7M equity and £3M non-dilutive

Solutions
Best in class in vitro models for accurate predictions of in vivo outcomes

  • Most physiologically relevant in vitro models
  • More predictive models for better in vivo outcomes, outperforming other existing in vitro models
  • Recapitulates the complexity and architecture of human tissues
  • Enables cross-species comparative studies
  • Ideal for human diseases where no other models are available (e.g., retina)
  • More suited to High Throughput screening than other models currently available
  • More cost effective than other models currently available

Model Applications

  • Disease modelling
  • Gene therapy applications
  • Respiratory infectious diseases
  • Vaccine development
  • Gene editing applications
  • Translational science (mechanistic insights)
  • Safety and efficacy studies
  • DMPK and toxicology studies
  • Transporter studies
  • Drug-drug interactions (DDI) studies
  • Xenobiotic metabolism of chemicals
  • Drug mechanism of action